Argus
•
May 27, 2026
LFST: What does Argus have to say about LFST?
Summary
LifeStance Health Group Inc has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
SHC: Raising target price to $15.00
May 27, 2026
•
SHC
ALHC: Lowering target price to $15.00
May 27, 2026
•
ALHC
PRVA: Lowering target price to $21.00
May 27, 2026
•
PRVA
CTKB: What does Argus have to say about CTKB?
May 27, 2026
•
CTKB
SHC: Lowering target price to $14.00
May 20, 2026
•
SHC
